Therapeutics: CD19 ligand (CD19L); tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)

Studies in cell culture, mice and patient samples suggest a CD19L-TRAIL fusion protein could help treat B cell precursor ALL. Over 93% and 50% of primary leukemia cells from patients with the disease ...